Traditional knowledge: Protecting age-old practices

The Chinese have sworn by it for generations. India is known for lauding its healing powers. In tribal regions of sub-Saharan Africa it’s a viable alternative to over-the-counter pharmaceuticals.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Asia

Chinese biotech strikes billion dollar deal in nextgen cancer race

20 January 2026 Magic Circle and major US firm among dealmakers who worked on the licensing agreement for a bispecific antibody candidate, marking another significant outbound licensing deal from China’s biopharma sector.

Asia

Novo Nordisk secures China win ahead of key patent expiration

6 January 2026 Danish pharma giant notches an important victory in a huge market for semaglutide, but faces a patent cliff and mounting challenges across India, Canada and the US.

Asia

Novo Nordisk ramps up semaglutide defence as generics lurk

9 December 2025 The Danish pharma giant is expanding its patent defence in India as multiple generics prepare to challenge its blockbuster diabetes and weight-loss drug ahead of 2026 patent expiry.

More features

Chinese biotech strikes billion dollar deal in nextgen cancer race

Final call: Who are the world’s best in-house counsel?

How AI will be shaped by legal and regulatory developments in 2026

Novo Nordisk secures China win ahead of key patent expiration

Key EU and UK regulatory changes to watch for in 2026

From Edwards to Insulet: Three key medical device cases of 2025

5 ways the USPTO director is changing US innovation

WATCH: “Try and see” – an underestimated standard for obviousness before the EPO?

Traditional knowledge: Protecting age-old practices

More on this story

Editor's picks

Editor's picks

More features